New osteoarthritis drug candidate passes first safety check
NCT ID NCT07429565
First seen Mar 12, 2026 · Last updated May 14, 2026 · Updated 11 times
Summary
This early-stage study tested a new medicine called APPA-1 in 40 healthy volunteers and people with osteoarthritis. The main goal was to see if it is safe and how the body processes it. Researchers also looked at how food and gender affect the drug. This is a first step toward finding a new treatment to ease osteoarthritis symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Royal Liverpool University Hospitals NHS Foundation Trust
Liverpool, Merseyside, L7 8XP, United Kingdom
-
University of Liverpool
Liverpool, L69 7ZB, United Kingdom
Conditions
Explore the condition pages connected to this study.